Influence of the route of sensitization on local and systemic immune responses in a murine model of type I allergy

Clinical and Experimental Immunology

Volumn 137, Issue 1, 2004, Pages 12-18

  Repa, A ^a,b   Wild, C ^a   Hufnagl, K ^a   Winkler, B ^a   Bohle, B ^a   Pollak, A ^b   Wiedermann, U ^a,b  

^a Department of Pathophysiology ^*  (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Local immune response; Murine model; Route; Sensitization; Systemic immune response; Type I allergy

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G; INTERLEUKIN 4; INTERLEUKIN 5; POLLEN ANTIGEN; POLLEN EXTRACT;

AEROSOL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BASOPHIL DEGRANULATION; BIRCH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; FEMALE; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; IN VITRO STUDY; LUNG ALVEOLUS CELL; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION; SPLEEN CELL;

AEROSOLS; ALLERGENS; ANIMALS; BASOPHILS; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; HYPERSENSITIVITY, IMMEDIATE; IMMUNITY; IMMUNIZATION; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; MICE; MICE, INBRED BALB C; RATS; SPLEEN;

EID: 3042739924     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02519.x     Document Type: Article

References (31)

1. Hamid QA, Minshall E. In situ detection of cytokines in allergic inflammation. Adv Exp Med Biol 1996; 409:327-35.
2. Coffman RL, Lebman DA, Rothman P. Mechanism and regulation of immunoglobulin isotype switching. Adv Immunol 1993; 54:229-70.
3. de Vries JE. The role of IL-13 and its receptor in allergy and inflammatory responses. J Allergy Clin Immunol 1998; 102:165-9.
4. Punnonen J, Aversa G, Cocks BG et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA 1993; 90:3730-4.
5. Emson CL, Bell SE, Jones A, Wisden W, McKenzie AN. Interleukin (IL)-4-independent induction of immunoglobulin (Ig) E, and perturbation of T cell development in transgenic mice expressing IL-13. J Exp Med 1998; 188:399-404.
6. Aalbers R, Kauffman HF, Vrugt B, Koeter GH, de Monchy JG. Allergen-induced recruitment of inflammatory cells in lavage 3 and 24 h after challenge in allergic asthmatic lungs. Chest 1993; 103:1178-84.
7. Gauvreau GM, Watson RM, O'Byrne PM. Kinetics of allergen-induced airway eosinophilic cytokine production and airway inflammation. Am J Respir Crit Care Med 1999; 160:640-7.
8. O'Byrne PM, Inman MD, Parameswaran K. The trials and tribulations of IL-5, eosinophils, and allergic asthma. J Allergy Clin Immunol 2001; 108:503-8.
9. Lloyd CM, Rankin SM. Chemokines in allergic airway disease. Curr Opin Pharmacol 2003; 3:443-8.
10. Lloyd CM, Delaney T, Nguyen T et al. CC chemokine receptor (CCR) 3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo. J Exp Med 2000; 191:265-74.
11. Park SW, Kim do J, Chang HS et al. Association of interleukin-5 and eotaxin with acute exacerbation of asthma. Int Arch Allergy Immunol 2003; 131:283-90.
12. Brown JR, Kleimberg J, Marini M et al. Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation. Clin Exp Immunol 1998; 114:137-46.
13. Sulakvelidze I, Inman MD, Rerecich T, O'Byrne PM. Increases in airway eosinophils and interleukin-5 with minimal bronchoconstriction during repeated low-dose allergen challenge in atopic asthmatics. Eur Respir J 1998; 11:821-7.
14. Wills-Karp M, Chiaramonte M. Interleukin-13 in asthma. Curr Opin Pulm Med 2003; 9:21-7.
15. Marsella R, Olivry T. Animal models of atopic dermatitis. Clin Dermatol 2003; 21:122-33.
16. Isenberg-Feig H, Justice JP, Keane-Myers A. Animal models of allergic asthma. Curr Allergy Asthma Rep 2003; 3:70-8.
17. Helm RM. Food allergy animal models: an overview. Ann N Y Acad Sci 2002; 964:139-50.
18. Wiedermann U, Jahn-Schmid B, Fritsch R et al. Effects of adjuvants on the immune response to allergens in a murine model of allergen inhalation: cholera toxin induces a Th1-like response to Bet v 1, the major birch pollen allergen. Clin Exp Immunol 1998; 111:144-51.
19. Gorham JD, Guler ML, Steen RG et al. Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses. Proc Natl Acad Sci USA 1996; 93:12467-72.
20. Jarolim E, Tejkl M, Rohac M et al. Monoclonal antibodies against birch pollen allergens: characterization by immunoblotting and use for single-step affinity purification of the major allergen Bet v 1. Int Arch Allergy Appl Immunol 1989; 90: 54-60.
21. Repa A, Grangette C, Daniel C et al. Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy. Vaccine 2003; 22:87-95.
22. Bauer L, Bohle B, Jahn-Schmid B et al. Modulation of the allergic immune response in BALB/c mice by subcutaneous injection of high doses of the dominant T cell epitope from the major birch pollen allergen Bet v 1. Clin Exp Immunol 1997; 107:536-41.
23. Winkler B, Baier K, Wagner S et al. Mucosal tolerance as therapy of type I allergy: intranasal application of recombinant Bet v 1, the major birch pollen allergen, leads to the suppression of allergic immune responses and airway inflammation in sensitized mice. Clin Exp Allergy 2002; 32:30-6.
24. Wiedermann U, Herz U, Baier K et al. Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in mice. Int Arch Allergy Immunol 2001; 126: 68-77.
25. Herrick CA, MacLeod H, Glusac E, Tigelaar RE, Bottomly K. Th2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4. J Clin Invest 2000; 105:765-75.
26. Nelde A, Teufel M, Hahn C et al. The impact of the route and frequency of antigen exposure on the IgE response in allergy. Int Arch Allergy Immunol 2001; 124:461-9.
27. Li L, Xia Y, Nguyen A et al. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol 1999; 162:2477-87.
28. Mojtabavi N, Dekan G, Stingl G, Epstein MM. Long-lived Th2 memory in experimental allergic asthma. J Immunol 2002; 169:4788-96.
29. Banfield CC, Callard RE, Harper JI. The role of cutaneous dendritic cells in the immunopathogenesis of atopic dermatitis. Br J Dermatol 2001; 144:940-6.
30. Upham JW, Stumbles PA. Why are dendritic cells important in allergic diseases of the respiratory tract? Pharmacol Ther 2003; 100:75-87.
31. Schmitz J, Assenmacher M, Radbruch A. Regulation of T helper cell cytokine expression: functional dichotomy of antigen-presenting cells. Eur J Immunol 1993; 23:191-9.